Introduction

This page provides a comprehensive analysis of the known insider trading history of Andrew H Lane. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Andrew H Lane has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABT / Abbott Laboratories EXECUTIVE VICE PRESIDENT 76,087
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Andrew H Lane. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Andrew H Lane as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-11-17 2021-11-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -10,000 76,087 -11.62 130.01 -1,300,090 9,891,995
2021-08-31 2021-08-27 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -135,925 0 -100.00
2021-08-31 2021-08-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -135,925 86,087 -61.22 125.48 -17,055,189 10,801,766
2021-08-31 2021-08-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 135,925 222,012 157.89 38.40 5,219,520 8,525,261
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5,065 86,076 -5.56 121.58 -615,803 10,465,120
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 25,319 91,141 38.47
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 71,070 71,070
2020-05-07 2020-05-05 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -38,732 135,925 -22.18
2020-05-07 2020-05-05 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -41,268 0 -100.00
2020-05-07 2020-05-05 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -80,000 65,822 -54.86 92.00 -7,360,104 6,055,710
2020-05-07 2020-05-05 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 38,732 145,822 36.17 38.40 1,487,309 5,599,565
2020-05-07 2020-05-05 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 41,268 107,090 62.70 48.90 2,018,005 5,236,701
2020-04-03 2020-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -365 65,822 -0.55 78.91 -28,802 5,194,014
2020-04-03 2020-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 1,659 66,187 2.57
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5,243 64,523 -7.52 79.19 -415,193 5,109,576
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 23,828 69,766 51.87
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 126,435 126,435
2019-06-14 2019-06-12 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -73,424 41,268 -64.02
2019-06-14 2019-06-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -73,424 45,938 -61.51 81.42 -5,978,197 3,740,281
2019-06-14 2019-06-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 73,424 119,362 159.83 48.90 3,590,434 5,836,802
2019-04-02 2019-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -365 45,932 -0.79 79.94 -29,178 3,671,804
2019-04-02 2019-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 1,659 46,297 3.72
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5,095 44,638 -10.24 77.23 -393,487 3,447,393
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 23,150 49,733 87.09
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 115,055 115,055
2018-08-31 2018-08-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 26,583 -0.37 67.12 -6,712 1,784,278
2018-08-31 2018-08-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 26,583 -0.37 67.12 -6,712 1,784,278
2018-08-31 2018-08-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 26,679 -0.37 67.12 -6,712 1,790,697
2018-08-31 2018-08-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 26,779 -0.37 67.12 -6,712 1,797,406
2018-08-31 2018-08-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -8,697 26,879 -24.45 67.11 -583,664 1,803,877
2018-06-05 2018-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -602 35,676 -1.66 61.53 -37,041 2,195,144
2018-06-05 2018-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 3,007 36,276 9.04
2018-04-03 2018-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -332 33,269 -0.99 59.92 -19,893 1,993,478
2018-04-03 2018-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 1,659 33,601 5.19
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2,413 31,942 -7.02 60.55 -146,107 1,934,088
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 12,061 34,355 54.10 60.55 730,294 2,080,195
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -605 22,294 -2.64 60.17 -36,403 1,341,430
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 182,935 182,935
2017-07-05 2017-06-30 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes 0 0
2017-07-05 2017-06-30 4/A ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -327 22,566 -1.43 48.73 -15,935 1,099,641
2017-06-02 2017-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -602 22,893 -2.56 45.66 -27,487 1,045,294
2017-06-02 2017-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 3,007 23,495 14.68
2017-04-04 2017-04-01 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 34,424 34,424
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -1,328 20,488 -6.09 45.46 -60,371 931,384
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 6,640 21,816 43.75
2017-02-22 2017-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -605 15,176 -3.83 44.69 -27,037 678,215
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 112,484 112,484
2016-07-05 2016-06-30 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -327 15,781 -2.03 38.57 -12,612 608,673
2016-06-03 2016-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -602 16,108 -3.60 39.63 -23,857 638,360
2016-06-03 2016-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 3,007 16,710 21.94
2016-02-23 2016-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -605 13,703 -4.23 38.53 -23,311 527,977
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 174,657 174,657
2015-06-03 2015-06-01 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 114,692 114,692
2015-06-03 3 ABT ABBOTT LABORATORIES
Common shares without par value
28,616
2015-06-03 3 ABT ABBOTT LABORATORIES
Common shares without par value
28,616
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)